• PF-562271 HCl for FAK/Pyk2 Cancer Research

  2026-09-08

  PF-562271 HCl gives cancer researchers a reversible, ATP-competitive way to interrogate FAK/Pyk2 signaling across adhesion, migration, tumor growth, and microenvironment assays. This workflow-focused guide connects phospho-FAK readouts with radiotherapy and checkpoint-blockade models while clearly separating established evidence from testable extensions.

• ARCA EGFP mRNA (5-moUTP): Workflow Strategy

  2026-09-08

  A mechanism-driven guide to using ARCA EGFP mRNA (5-moUTP) as a fluorescence-based transfection control, with practical guidance on assay design, storage, translational relevance, and experimental interpretation.

• Deferasirox Fe3+ Chelate: From PK to Assay Design

  2026-09-07

  Deferasirox Fe3+ chelate connects the clinical pharmacology of Exjade with practical assay design for iron overload treatment research. This article explains how chemical form, solubility, controls, and translational context should shape beta-thalassemia iron chelation experiments.

• Sulfo-Cy3 NHS Ester for Vascular Assays

  2026-09-07

  Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye for designing aqueous protein-tracking assays around the AIBP–LRP2–HDL–miR-223 pathway. This guide connects its NHS-amine chemistry and spectral properties to rigorous vascular remodeling experiments while distinguishing particle uptake from downstream signaling.

• ac4C–Gm26917 Control of FGSC Translation

  2026-09-05

  This study identifies an ac4C–Gm26917–EEF1A1–Rpl10 pathway that connects lncRNA modification with ribosome-associated translation in female germline stem cells. By integrating acRIP-seq, RIC-seq, and ribosome profiling, it shows that ac4C supports Gm26917 stability and spatial recruitment of Rpl10 mRNA, thereby preserving protein synthesis and stem-cell maintenance.

• D-N-Acetylgalactosamine: Protocol & QC Guide

  2026-09-04

  This guide provides practical handling, solvent, storage, and quality-control instructions for D-N-Acetylgalactosamine (SKU B7904) in glycoprotein and neurological research workflows. It is suitable for controlled aqueous or compatible DMSO preparations, but not for ethanol-based protocols or long-term storage of prepared solutions.

• DiscoveryProbe Bioactive Compound Library Plus for TSA

  2026-09-04

  Use the DiscoveryProbe Bioactive Compound Library Plus to connect thermal stability shifts with pathway-level biology, from bacterial sensor ligand discovery to cellular validation. Its 5,072 pre-dissolved compounds support efficient triage, while orthogonal binding and phenotype assays help separate actionable ligands from assay artifacts.

• G007-LK Tankyrase 1/2 Inhibitor Workflow

  2026-09-03

  G007-LK provides a selective way to connect tankyrase activity with AXIN stabilization, β-catenin turnover, and Hippo-pathway responses. This practical guide covers pathway-focused assays, APC-mutant colorectal models, hepatocellular carcinoma extensions, and troubleshooting strategies for reproducible results.

• DRD2 Variants and Pathogenic G Protein Signaling

  2026-09-03

  A 2024 Biochemical Pharmacology study compared two pathogenic DRD2 variants associated with hyperkinetic movement disorders and identified stronger constitutive and agonist-driven G protein signaling as a likely explanation for the greater severity of Met374Arg disease. By combining cellular pharmacology, second-messenger analysis, receptor stability testing, and molecular dynamics simulations, the work connects variant-specific receptor behavior with clinical differences while illustrating how orthogonal assays can strengthen mechanistic interpretation.

• Covalent HPV-16 E6 Inhibitors Restore p53

  2026-09-02

  The reference study identifies a genotype-defined vulnerability in HPV-16–positive cancer by covalently and irreversibly targeting a cysteine near the E6AP-binding interface of the viral E6 oncoprotein. Inhibition restored p53 activity, triggered apoptosis or senescence, and suppressed cervical and oropharyngeal tumor xenografts, providing a mechanistic framework for targeted HPV-associated cancer research.

• BRD4–RAC1 Co-Targeting in Breast Cancer

  2026-09-02

  The reference study identifies combined BRD4 and RAC1 inhibition as a subtype-aware strategy that suppresses breast cancer growth, migration, stemness, and xenograft tumorigenesis. Its mechanistic contribution is to connect this treatment response with disruption of the c-MYC–G9a–FTH1 axis and downregulation of HDAC1, providing a framework for studying chromatin regulation alongside oncogenic signaling.

• ATRX Loss Sensitizes Glioma to PDGFR Inhibitors

  2026-09-01

  The 2022 Cancers study identified a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells were more sensitive to several receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient counterparts. Its findings support ATRX status as a biomarker for interpreting RTK inhibitor studies and for evaluating combinations with temozolomide, while also highlighting the need for in vivo and clinical validation.

• From E6 Inhibition to Senescence Translation

  2026-09-01

  Covalent HPV-16 E6 inhibition illustrates how on-target restoration of p53 can produce senescence as a therapeutically relevant phenotype. This article shows how the Cell Senescence β-Galactosidase Staining Kit can help translational teams validate that phenotype while avoiding overinterpretation of a single biomarker.

• Cy5 Goat Anti-Mouse IgG (H+L) Workflow

  2026-08-31

  Turn mouse-primary immunostaining into a sensitive, workflow-ready readout for ferritin vaccine studies, pseudovirus assays, and cell-surface binding experiments. This guide combines Cy5 fluorescence, practical controls, and troubleshooting decisions for IHC, ICC, and flow cytometry.

• Dinaciclib (SCH727965) for CDK Assays

  2026-08-31

  Dinaciclib (SCH727965) provides a mechanism-aware way to connect CDK inhibition with cell-cycle arrest, apoptosis, and tissue-boundary behavior. This guide translates its multi-CDK activity into practical oncology assays, developmental imaging experiments, controls, and troubleshooting decisions.

8025 records 1/535 page Next 12345 下5页 Last page